Gastric Cancer Open Access
Copyright ©The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 7, 2005; 11(33): 5123-5128
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5123
Adenocarcinoma of gastric cardia in the elderly: Surgical problems and prognostic factors
Natale Di Martino, Giuseppe Izzo, Angelo Cosenza, Francesco Torelli, Antonio Brillantino, VIII Service of General Surgery and Gastroenterological Physiopathology, Second University of Study of Naples, Italy
Guido Cerullo, Department of General Surgery and Surgical Oncology, UO Surgical Oncology, University of Siena, Italy
Alberto del Genio, I Division of General and Gastroenterological Surgery, Second University of Study of Naples, Italy
Author contributions: All authors contributed equally to the work.
Supported by the Second University of Study of Naples
Correspondence to: Professor Natale Di Martino, c/o VIII Servizio di Chirurgia Generale e Fisiopatologia Gastroenterologica, Seconda Università degli Studi di Napoli, Piazza Miraglia, 2-80135, Napoli, Italy. natale.dimartino@unina2.it
Telephone: +39-81-5665055 Fax: +39-81-5665055
Received: January 3, 2005
Revised: January 23, 2005
Accepted: January 26, 2005
Published online: September 7, 2005

Abstract

AIM: To analyze retrospectively, our results about patients who underwent surgical treatment for adenocarcinoma of the cardia in relation to age, in order to evaluate surgical problems and prognostic factors.

METHODS: From January 1987 to March 2003, 140 patients with adenocarcinoma of the cardia underwent resection in the authors’ institution. They were divided into three groups with regard to age. Patients <70 and >60 year old (31) were excluded; we also excluded 18 out of 109 patients with poor general status or systemic metastases. So, we compared 51 elderly (≥ 70 year old) and 58 younger patients (≤ 60 year old). The treatment was esophagectomy for type I tumors, and extended gastrectomy and distal esophagectomy for type II and III lesions.

RESULTS: Laparotomy was carried out in 91 patients (83.4%), 38 in the elderly (74.5%) and 53 in younger patients (91.3%, P<0.05). Primary resection was performed in 81 cases (89%) without significant differences between the two groups. Postoperative death was higher in the elderly (12.1%) than the other group (4.1%, P<0.05), while morbidity was similar in both groups. A curative resection (R0) was performed in 59 patients (72.8%), 69.6% in the elderly and 75% in the younger group (P>0.05). The overall 3- and 5-year survival rates were 26.7% and 17.8% respectively for the elderly and 40.7% and 35.1% respectively for younger patients (P = 0.1544). Survival rates were significantly associated with R0 resection, pathological node-positive category and tumor differentiation in both groups.

CONCLUSION: As the age of the general population increases, more elderly patients with gastric cardia cancer will be candidates for surgical resection. Age alone should not preclude surgical treatment in elderly patients with gastric cardia cancer and a tumor resection can be carried out safely. Certainly, we should take care in defining the surgical treatment in elderly patients, particularly as regarding the surgical approach; although the surgical approach does not influence the survival rate, the transhiatal way still remains the best one due, to the lower incidence of respiratory morbidity and thoracic pain.

Key Words: Gastric cardia carcinoma; Esophagogastric junction carcinoma; Elderly; Surgery



INTRODUCTION

In the Western world, we observe a lower incidence of gastric and esophageal cancer in contrast with the annual increase in the adenocarcinoma of the esophagogastric junction (EGJ) equal to 5-10%[1-10]. Both for gastric adenocarcinoma and cardia cancer, we notice an increasing number of elderly patients[11-14]. Anyway, with regard to clinicopathological features of the adenocarcinoma of the EGJ in the elderly and its surgical problems in relation to age, few data have been published in the international literature. Adenocarcinoma of the EGJ has been defined as a tumor whose center is within 5 cm proximal and distal of the anatomical cardia, and today this tumor is considered as a separate neoplasm because of its distinctive prognostic and pathological features[4-6]. However, the surgical treatment of the cardia is still controversial, mainly regarding the extent of gastric and esophageal resection, the limphadenectomy, the surgical approach and the importance of adjuvant chemotherapy[4,5,15-17]. These themes are very important in order to define the treatment of old patients, especially for the increasing number of over 70 year old suffering from this neoplasm as well as from other comorbidities peculiar to old age.

The aim of this study is to analyze retrospectively, our results about patients who underwent surgical treatment for adenocarcinoma of the EGJ in relation to age, in order to evaluate surgical problems and prognostic factors, in particular in patients over 70 year old.

MATERIALS AND METHODS

Between January 1987 and February 2003, in our Institute, we observed 140 patients with adenocarcinoma of the EGJ. They were divided retrospectively into three groups with regard to age: (1) Group A: age ≥ 70 years old; (2) Group B: age ≤ 60 years old; (3) Group C: age < 70- and > 60-years old.

The 31 patients of group C were excluded in order to characterize better the other two groups. Group A consists of 51 patients (44 male, 7 female), and group B 58 patients (50 male, 8 female, Table 1). A retrospective study was done on these two groups of patients.

Table 1 Demographic and surgical data in 109 patients with adenocarcinoma of the EGJ.
Group A (51)1Group B (58)1PTotal (109)
Median age (±SD)75.4±3.153.7±5.6P<0.0562.6±13.8
Sex ratio (M/F)4.8/16.2/1P<0.055.5/1
Operability (%)38 (74.5)53 (91.3)P<0.0591 (83.4)
Primary resection (%)33 (86.8)48 (90.5)NS81 (89)
Postoperative death (%)4 (12.1)2 (4.1)P<0.056 (7.4)
Morbidity (%)16 (48.4)16 (33.3)NS32 (39.5)
Mean hospital stay (±SD)19.3±7.1 d18.1±6.3 dNS19±6.9 d

The surgical risk has been evaluated preoperatively with ASA score[18]. Eighteen out of 109 patients were excluded, 10 for poor general status with ASA score >3 (nine in group A, one in group B) and 8 for systemic metastases on preoperative staging (four in group A, four in group B). So, a total of 91 patients with gastric cardia cancer underwent laparotomy and only 81 underwent surgical resection. The surgical procedure was considered curative (R0), if gross tumor tissue including the metastatic lymph nodes were removed completely and the microscopic examination revealed no cancer cells at both proximal and distal margins. The procedure was considered palliative (R1), if microscopic disease was left behind. Resection specimens were assessed by an experienced pathologist. Staging is reported according to the most recent version of the UICC/AJCC guidelines for esophageal cancer (type I tumors) or gastric cancer (type II and III tumors)[19,20].

A particular effort has been made to identify areas with intestinal metaplasia in the distal esophagus and in the region of the cardia in all resection specimens. The retrospectively collected data included demographic parameters, histomo-rphologic tumor characteristics, the presence of associated intestinal metaplasia in the distal esophagus (Barrett’s esophagus), the type of resection, post-operative 30-d death rate, morbidity, the depth of tumor invasion (pT), the pN category, the presence of residual disease on intraoperative assessment and histopathologic analysis of the removed specimen.

Surgical approach

The choice of surgical approach was based on the tumor type and on the goal of achieving a complete macroscopic and microscopic tumor resection, both in elderly and younger patients. Regardless of the surgical approach, we have recently believed in the transhiatal approach according to Pinotti’s technique as a more valid alternative than the transthoracic approach. In general, a radical transmediastinal or transthoracic en bloc esophagectomy with resection of the proximal stomach has been the procedure of choice in 14 patients with type I tumors (seven in group A, seven in group B). Radical transmediastinal esophagectomy and resection of the proximal stomach was performed by a laparotomy and wide exposure of the lower posterior mediastinum by anterior splitting of the diaphragmatic hiatus and a left cervical incision. Extended esophagectomy was associated with proximal gastric resection in nine patients and with total gastrectomy in 5 cases. An extended total gastrectomy with transhiatal resection of the distal esophagus according to Pinotti’s technique was performed in 42 patients with type III tumors. In 25 patients with type II tumors, an attempt was usually made to achieve a complete tumor resection by means of an extended gastrectomy with transhiatal resection of the distal esophagus according to Pinotti’s technique. Lymphadenectomy comprised an en bloc removal of all lymphatic tissue in the lower posterior mediastinum, along the cardia, proximal two-thirds of the lesser curvature, and the fundus, and along the common hepatic and splenic artery toward the celiac axis. A transthoracic en bloc esophagectomy with resection of the proximal stomach was performed using a right posterolateral thoracotomy and laparotomy and included an extended en bloc mediastinal lymphadenectomy and an abdominal lymphadenectomy (two-field lymphadenectomy), as described above. The reconstruction after transmediastinal or transthoracic esophagectomy was performed with a narrow gastric tube or colon interposition and a cervical or high intrathoracic anastomosis. The extended total gastrectomy has always included a wide splitting of the diaphragmatic hiatus, transhiatal resection of the distal esophagus, and en bloc lymphadenectomy of the lower posterior mediastinum, in addition to a formal D2 lymphadenectomy (i.e., lymph node stations 1-11 of the Japanese classification)[21]. A mediastinal Roux-en-Y end-to-side esophago-jejunostomy performed with a circular stapler, was the reconstruction procedure of choice, after extended total gastrectomy and distal esophagectomy.

Statistical analysis

The survival status of our patients was ascertained between January and February 2003 and the follow-up was completed.

Data are shown as prevalence or mean±SD. Continuous data were compared by the Mann-Whitney test, ordinal data by the χ2-test. Survival rate was analyzed by the Kaplan-Meier method and log-rank test. Prognostic factors were assessed by means of Cox regression analyses. P<0.05 was considered significant.

RESULTS

Regarding demographic data, both groups showed a prepon-derance of the male sex (Group A: M/F 4.8:1; Group B: M/F 6.2:1), but the male to female ratio was higher in the younger group than in the older group (P<0.05). Median age was 75.4±3.1; (range 70-84) for over 70 year old patients and 53.7±5.6; (range 32-60) in the other group (Table 1). The most common comorbidities in both groups were diabetes mellitus, coronary artery disease, hypertension and chronic obstructive pulmonary disease. Patients were divided into three types of tumor according to Siewert’s classification (Figure 1). Laparotomy was carried out in 91 patients (83.4%), 38 in group A (74.5%) and 53 in group B (91.3%) (P<0.05). Primary resection was performed in 81 cases (89%), 33 in group A (86.8%) and 48 in group B (90.5%) (Table 1). There were no differences between the two groups regarding tumor stage.

Figure 1
Figure 1 Subdivision of the 81 patients with adenocarcinoma of the EGJ, according to Siewert’ Classification. Group A: ≥70 years old; group B: ≤60 years old. Type I A vs Type I B P>0.05; Type II A vs Type II B P>0.05; Type III A vs Type III B P>0.05.

In type I tumor, we observed a prevalence (71.4%) of associated intestinal metaplasia in the distal esophagus (Barrett’s esophagus) of elderly patients; rarely it was noticed in type II (10% vs 13.3%; P>0.05) or in type III (11.7% vs 3.8%; P>0.05, Table 2). In types II and III, there was a prevalence of grading G2 (P<0.05) compared to type I, independent of the age.

Table 2 Histopathologic data in 81 patients that underwent surgical resection for adenocarcinoma of the EGJ.
Group A (33, %)1Group B (48, %)1P
Intestinal metaplasia71.471.4NS
Curative resection (R0)69.675NS
Tumor involvement of resection margin34.1NS
Lymph nodes involvement (N+)60.662.5NS

A curative resection (R0) was performed in 59 patients (72.8%), 69.6% in group A and 75% in group B respectively (Table 2). Three out of 59 patients treated with resection of the distal esophagus had tumor infiltration of resection margins. Fifty patients (61.7%) had positive lymph nodes, 20 in group A (60.6%) and 30 (62.5%) in group B, respectively (Table 3). Analysis of the pattern of lymphatic spread showed a most important metastatic involvement of lower posterior mediastinum and paracardial stations for type I and abdominal lymph node stations for types II and III, without significant differences between the two groups (A vs B: P>0.05). A greater percentage of positive lymph nodes was noticed in elderly patients (25% vs 17.6%), but it was statistically insignificant.

Table 3 Histopathologic data regarding pN category in 81 patients that underwent surgical resection for adenocarcinoma of the EGJ.
pN categoryGroup A (33)1Group B (48)1P
Patients N013 (39.3)218 (37.5)2NS
Patients N+20 (60.6)230 (62.5)2NS
Assessed lymph nodes436511NS
Positive lymph nodes109 (25)290 (17.6)2NS

Postoperative death was 12.1% (4/33) in elderly patients and 4.1% (2/48) in the other group (P<0.05), without any correlation with sex, type of tumor, extent of resection and stage. Regardless of morbidity, there are no significant differences between the two groups. The most frequent complications were respiratory insufficiency and anastomotic leakage. The mean hospital stay (SD) was 19.3±7.1 d for group A and 18.1±6.3 d for group B (P>0.05, Table 1).

The overall 3- and 5-year survival rates were 26.7% and 17.8% respectively for group A and 40.7% and 35.1% respectively for group B (P = 0.1544, Figure 2). The worst results were observed for type I in both groups (Figures 3A and B). We noticed a difference in survival rate for types I and II between group A and B, but not significantly. As regards the type III survival rates were similar in both groups (Figures 4A-C).

Figure 2
Figure 2 The 5-year survival rates of 113 patients with adenocarcinoma of the EGJ. The younger patients showed a better survival rate than the elderly (P = 0.1544). Group A: ≥70 years old; group B: ≤60 years old. Kaplan-Meier and log-rank test.
Figure 3
Figure 3 Survival curves according to Siewert’s classification in the elderly (A) and in the younger group (B). In both groups the worst survival rate regarding type I. Group A: ≥70 years old; group B: ≤60 years old. Kaplan-Meier and log-rank test.
Figure 4
Figure 4 Survival curves according to Siewert’s classification for type I (A), type II (B) and type III (C), respectively. There is a difference in survival rate only for types I and II between groups A and B, but not of much significance. Group A: ≥70 years old; group B: ≤60 years old. Kaplan-Meier and log-rank test.

Analysis of prognostic factors showed significant differences in both groups regarding: (1) tumor resection (R0 vs R1-2, P<0.05); (2) lymph node involvement (N0 vs N+, P<0.05); (3) pT categories (P<0.05);

Statistical analysis showed that elderly patients had lower 5-year survival rate both into R0 (21% vs 49.9%) and N0 (24.1% vs 70%) category (P<0.0001) (Figures 5A and B). Differently, surgical approach and extent of esophago-gastric resection does not influence significantly the survival rates, both in the elderly and in the other group. The extent of esophago-gastric resection for type II tumor still remains a subject of controversy and debate. Regarding this type of tumor, we did not observe any significant improvement in patients that underwent total esophagectomy (Figure 6).

Figure 5
Figure 5 Overall 5-year survival rates of 81 patients with resected adenocarcinoma of the EGJ regarding type of resection (R0 vs R1-2) (A) and pN category (B). Elderly patients showed a lower 5-year survival rate than that of younger patients, both for pN0 category and curative resection (R0). Group A: ≥70 years old; group B: ≤60 years old. Kaplan-Meier and log-rank test.
Figure 6
Figure 6 Survival rates of elderly and younger patients regarding the extent of esophagogastric resection for type II tumor: total gastrectomy with distal esophagectomy (TG+DE) vs total gastrectomy with total esophagectomy (TG+TE) (P = 0. 4697). Both in the elderly and younger patients with type II tumor, total esophagectomy did not improve survival rates significantly. Group A: ≥70 years old; group B: ≤60 years old. Kaplan-Meier and log-rank test.
DISCUSSION

There are no major controversies in the surgical therapy of patients with esophageal and gastric cancer, but the management of patients with adenocarcinoma of the EGJ continues to be a matter of debate. Despite their rising incidence, there are marked discrepancies in the definition of such tumors, the selection of the surgical approach, and the outcome of surgical therapy[4,6,7,15]. The classification of Siewert, based purely on anatomical/topographic parameters, is needed for a valid comparison of data from various centers and assessment of different diagnostic and therapeutic approaches[4-6].

Anyway, the evaluation of our surgical results in relation with age was very difficult because not much information was available in the international literature. By comparison of two groups of patients that underwent surgical resection for adenocarc-inoma of the EGJ, we did not observe significant differences as regarding demographic data and survival rates. Younger patients showed a better but not a significant overall survival rate than the elderly people. In our study, this result is independent of the type of tumors, but the worst survival rate regarding type I, probably due to the inefficacious endoscopic screening in patients with EG chronic reflux disease. In elderly patients, we also observed that operability was significantly lower (P<0.05) while post-operative death was higher (P<0.05) than in the other group. Probably, both operability and primary resection are lower in elderly patients due to their age-related comorbidity. Morbidity was higher but not significant in elderly patients[11,22]. Unlike other authors[11], R0 and N0 categories had significantly lower survival rates in the elderly group. It is very difficult to interpret these results, so further studies are needed. There were no differences between the two groups regarding other parameters. Moreover, in patients with type II tumor total esophagectomy did not improve survival rates[4,5].

A radical surgery is also necessary in distal esophagectomy through a safety margin of 3 cm according to some authors or 10 cm according to others[4,5,9,23-25]. In our experience, it is enough to have a safety distance of 5 cm from the upper margin of the tumor to ensure R0 resection. Therefore, the aim of the surgical treatment of the adenocarcinoma of the EGJ is to get a radical oncological resection, taking care of achieving R0 resection.

In conclusion, gastric cardia cancer is usually diagnosed in an advanced stage and is still associated with poor prognosis, particularly in elderly patients. As the age of the general population increases, more elderly patients with gastric cardia cancer will be candidates for surgical resection. In our study, as also observed by other authors for gastric cancer[26], the overall survival data were similar in both groups. Survival rate is strongly linked to curative resection (R0), lymph nodes involvement and stage of disease, which is advanced in more than half of patients. In our experience, unlike other authors, worst results regarding type I, is due to the inefficacious endoscopic screening in patients with EG chronic reflux disease which is correlated to intestinal metaplasia, independent of age. However, just like other authors[3], we observed a high percentage of Barrett’s esophagus in elderly patients over 70 years. So, endoscopic secondary prevention should be enhanced in patients with EG reflux disease and particularly in the elderly.

Other authors just observed that an oncologically correct surgical procedure can safely be prosecuted, because age alone should not preclude gastric resection in elderly patients suffering from gastric cancer[26,27]. Regarding the adenocarcinoma of the EGJ, the extent of distal esophagectomy for type II tumor does not influence survival rates on the condition that it achieves a curative resection (R0). The role of lymphadenectomy continues to be a matter of debate. We agree with the necessity of extended lymphadenectomy by transthoracic[28,29] approach but, its potential benefits may be nullified by an associated increase in post-operative morbidity, particularly in over 70-year-old patients. However, we believe that the transhiatal approach according to Pinotti’s technique is a more valid alternative than the transthoracic approach, due to the lower incidence of respiratory morbidity and thoracic pain[7,9,30-32]. According to some authors, in selected cases, it is also possible to perform a distal esophagectomy entirely by laparoscopy, without the need for any thoracic or cervical access[33].

In conclusion, age alone should not preclude surgical treatment in elderly patients with gastric cardia cancer and a tumor resection can be carried out safely. Certainly, further studies are needed to confirm the peculiarities observed in elderly patients, just like lower operability and survival rates for type I-II tumors and R0-N0 categories, higher post-operative death and morbidity after thoracotomy. If these data should be confirmed, we should take care in defining the surgical treatment in elderly patients, particularly as regarding the surgical approach.

Footnotes

Co-first-authors: Natale Di Martino and Guido Cerullo

Science Editor Guo SY Language Editor Elsevier HK

References
1.  Cai L, Zheng ZL, Zhang ZF. Risk factors for the gastric cardia cancer: a case-control study in Fujian Province. World J Gastroenterol. 2003;9:214-218.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Mueller JD, Stein HJ, Oyang T, Natsugoe S, Feith M, Werner M, Rüdiger Siewert J. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer. 2000;89:1874-1882.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
3.  Pera M. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg. 2003;27:999-1008; discussion 1006-8.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 81]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
4.  Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction. Result of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann Surg. 2000;232:353-361.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 537]  [Cited by in F6Publishing: 521]  [Article Influence: 21.7]  [Reference Citation Analysis (0)]
5.  Mariette C, Castel B, Toursel H, Fabre S, Balon JM, Triboulet JP. Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg. 2002;89:1156-1163.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 77]  [Cited by in F6Publishing: 72]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
6.  Ichikura T, Ogawa T, Kawabata T, Chochi K, Sugasawa H, Mochizuki H. Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial carcinoma? World J Surg. 2003;27:334-338.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 31]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
7.  Hansson LE, Ekström AM, BergströmD Sc R, Nyrén O. Carcinoma of the gastric cardia: surgical practices and short-term operative results in a defined Swedish population. World J Surg. 2000;24:473-478.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 6]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
8.  Graham AJ, Finley RJ, Clifton JC, Evans KG, Fradet G. Surgical management of adenocarcinoma of the cardia. Am J Surg. 1998;175:418-421.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 45]  [Cited by in F6Publishing: 47]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
9.  Wayman J, Dresner SM, Raimes SA, Griffin SM. Transhiatal approach to total gastrectomy for adenocarcinoma of the gastric cardia. Br J Surg. 1999;86:536-540.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 41]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
10.  Bruno L, Nesi G, Montinaro F, Carassale G, Lassig R, Boddi V, Bechi P, Cortesini C. Clinicopathologic findings and results of surgical treatment in cardiac adenocarcinoma. J Surg Oncol. 2000;74:33-35.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
11.  Rabuñal RR, Pita SF, Rigueiro MT, Casariego EV, Pértega SD, García-Rodeja E, Abraira V. Presentation and prognosis of gastric cancer in patients aged 80 years and older. World J Surg. 2004;28:155-159.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 4]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
12.  Borch K, Jönsson B, Tarpila E, Franzén T, Berglund J, Kullman E, Franzén L. Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma. Br J Surg. 2000;87:618-626.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 74]  [Cited by in F6Publishing: 82]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
13.  Kitamura K, Yamaguchi T, Taniguchi H, Hagiwara A, Yamane T, Sawai K, Takahashi T. Clinicopathological characteristics of gastric cancer in the elderly. Br J Cancer. 1996;73:798-802.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 79]  [Cited by in F6Publishing: 87]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
14.  Gillison EW, Powell J, McConkey CC, Spychal RT. Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia. Br J Surg. 2002;89:344-348.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 90]  [Cited by in F6Publishing: 94]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
15.  Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert's classification applied to 177 cases resected at a single institution. J Am Coll Surg. 1999;189:594-601.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 74]  [Cited by in F6Publishing: 75]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
16.  Bumm R, Feussner H, Bartels H, Stein H, Dittler HJ, Höfler H, Siewert JR. Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma. World J Surg. 1997;21:822-831.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg. 1999;86:529-535.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 134]  [Cited by in F6Publishing: 138]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
18.  American Society of Anesthesiologist. New classification of physical status. Anesthesiology. 1963;24:111.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Tnm U Classification of Malignant Tumours; 6th Edition. New York: Wiley Liss 2002; .  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Cancer Staging Handbook; 6th Edition. New York: Wiley Liss 2002; .  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition -. Gastric Cancer. 1998;1:10-24.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2009]  [Cited by in F6Publishing: 1923]  [Article Influence: 74.0]  [Reference Citation Analysis (0)]
22.  Dhar DK, Kubota H, Tachibana M, Kotoh T, Tabara H, Watanabe R, Kohno H, Nagasue N. Long-term survival of transmural advanced gastric carcinoma following curative resection: multivariate analysis of prognostic factors. World J Surg. 2000;24:588-593.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 35]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
23.  Stipa S, Di Giorgio A, Ferri M. Surgical treatment of adenocarcinoma of the cardia. Surgery. 1992;111:386-393.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449-461.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 797]  [Cited by in F6Publishing: 787]  [Article Influence: 30.3]  [Reference Citation Analysis (0)]
25.  Stark SP, Romberg MS, Pierce GE, Hermreck AS, Jewell WR, Moran JF. Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophagus and cardia. Am J Surg. 1996;172:478-481.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 66]  [Cited by in F6Publishing: 67]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
26.  Coniglio A, Tiberio GA, Busti M, Gaverini G, Baiocchi L, Piardi T, Ronconi M, Giulini SM. Surgical treatment for gastric carcinoma in the elderly. J Surg Oncol. 2004;88:201-205.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 48]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
27.  Saidi RF, Bell JL, Dudrick PS. Surgical resection for gastric cancer in elderly patients: is there a difference in outcome? J Surg Res. 2004;118:15-20.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 47]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
28.  Chu KM, Law SY, Fok M, Wong J. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg. 1997;174:320-324.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 198]  [Cited by in F6Publishing: 154]  [Article Influence: 5.7]  [Reference Citation Analysis (0)]
29.  Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg. 2001;72:306-313.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 425]  [Cited by in F6Publishing: 384]  [Article Influence: 16.7]  [Reference Citation Analysis (0)]
30.  Hulscher JB, van Sandick JW, Tijssen JG, Obertop H, van Lanschot JJ. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg. 2000;191:143-148.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 148]  [Cited by in F6Publishing: 141]  [Article Influence: 5.9]  [Reference Citation Analysis (0)]
31.  Orringer MB, Marshall B, Stirling MC. Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg. 1993;105:265-276; discussion 276-277.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy for treatment of benign and malignant esophageal disease. World J Surg. 2001;25:196-203.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 107]  [Cited by in F6Publishing: 68]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
33.  Costi R, Himpens J, Bruyns J, Cadière GB. Totally laparoscopic transhiatal esophago-gastrectomy without thoracic or cervical access. The least invasive surgery for adenocarcinoma of the cardia? Surg Endosc. 2004;18:629-632.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 23]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]